Pictet Asset Management
TWST icon

Pictet Asset Management’s Twist Bioscience TWST Stock Holding History

Pictet Asset Management’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.7M Sell
108,267
-77,725
-42% -$5.06M 0.01% 671
2026
Q1 		$8.08M Sell
185,992
-36,655
-16% -$1.64M 0.01% 695
2025
Q4 		$7.3M Buy
222,647
+115,880
+109% +$3.62M 0.01% 737
2025
Q3 		$2.89M Sell
106,767
-3,002
-3% -$90.9K ﹤0.01% 839
2025
Q2 		$3.95M Sell
109,769
-6,657
-6% -$230K ﹤0.01% 810
2025
Q1 		$4.69M Buy
116,426
+108,295
+1,332% +$4.88M 0.01% 810
2024
Q4 		$378K Buy
8,131
+1,764
+28% +$79.7K ﹤0.01% 1519
2024
Q3 		$288K Sell
6,367
-626
-9% -$29.8K ﹤0.01% 1631
2024
Q2 		$345K Sell
6,993
-867
-11% -$35.4K ﹤0.01% 1452
2024
Q1 		$270K Buy
7,860
+2,029
+35% +$73.2K ﹤0.01% 1603
2023
Q4 		$215K Buy
+5,831
New +$135K ﹤0.01% 1710

Other funds holding TWST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Pictet Asset Management's TWST Position: Q2 2026 in Review

Pictet Asset Management reduced its Twist Bioscience (TWST) stake by 42% in Q2 2026, selling an estimated $5.06M and leaving 108,267 shares worth $10.7M. The position accounts for 0.01% of the portfolio, ranked #671.

Pictet Asset Management first reported a position in TWST in Q4 2023 and has held it in 11 quarters since. 335 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • Pictet Asset Management held 108,267 shares of Twist Bioscience worth $10.7M as of Q2 2026.
  • Pictet Asset Management sold 77,725 Twist Bioscience shares in Q2 2026, an estimated $5.06M.
  • Twist Bioscience made up 0.01% of Pictet Asset Management's portfolio in Q2 2026, its #671 holding.
  • Pictet Asset Management first reported a position in Twist Bioscience in Q4 2023 and has held it in 11 quarters since.
  • 335 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.